Surgery Partners, Inc. (NASDAQ:SGRY) Insider Sells $261,105.21 in Stock

Surgery Partners, Inc. (NASDAQ:SGRY – Get Rating) insider Bradley R. Owens sold 7,191 shares of the company’s stock in a transaction dated Wednesday, May 17th. The stock was sold at an average price of $36.31, for a total value of $261,105.21. Following the completion of the sale, the insider now owns 74,189 shares in the company, valued at approximately $2,693,802.59. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Surgery Partners Price Performance

Shares of Surgery Partners stock opened at $36.88 on Friday. The company has a fifty day moving average price of $35.34 and a 200 day moving average price of $31.81. The company has a quick ratio of 1.68, a current ratio of 1.83 and a debt-to-equity ratio of 0.86. Surgery Partners, Inc. has a twelve month low of $20.46 and a twelve month high of $41.80.

Surgery Partners (NASDAQ:SGRY – Get Rating) last announced its quarterly earnings results on Monday, May 1st. The company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.09. The firm had revenue of $666.20 million during the quarter, compared to analysts’ expectations of $644.16 million. Surgery Partners had a negative net margin of 3.51% and a positive return on equity of 0.59%. Equities analysts expect that Surgery Partners, Inc. will post 0.31 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on SGRY. JPMorgan Chase & Co. reduced their target price on Surgery Partners from $45.00 to $40.00 and set a “neutral” rating for the company in a report on Thursday, March 2nd. StockNews.com started coverage on Surgery Partners in a research report on Thursday. They set a “hold” rating for the company. Citigroup lifted their target price on Surgery Partners from $40.00 to $47.00 in a report on Tuesday, May 2nd. Mizuho assumed coverage on Surgery Partners in a research note on Friday, May 12th. They issued a “buy” rating and a $48.00 price target on the stock. Finally, Benchmark restated a “buy” rating and issued a $47.00 price target on shares of Surgery Partners in a research note on Monday, March 6th. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $43.27.

Hedge Funds Weigh In On Surgery Partners

Several large investors have recently modified their holdings of the stock. FMR LLC increased its stake in shares of Surgery Partners by 2.8% in the first quarter. FMR LLC now owns 18,904,157 shares of the company’s stock valued at $651,626,000 after purchasing an additional 513,573 shares during the period. Wellington Management Group LLP increased its stake in shares of Surgery Partners by 2.2% in the first quarter. Wellington Management Group LLP now owns 6,946,272 shares of the company’s stock valued at $239,438,000 after purchasing an additional 151,794 shares during the period. Durable Capital Partners LP increased its stake in shares of Surgery Partners by 174.3% in the fourth quarter. Durable Capital Partners LP now owns 5,853,995 shares of the company’s stock valued at $163,092,000 after purchasing an additional 3,719,766 shares during the period. Clearbridge Investments LLC boosted its holdings in shares of Surgery Partners by 1.6% in the first quarter. Clearbridge Investments LLC now owns 5,564,807 shares of the company’s stock valued at $191,819,000 after acquiring an additional 85,490 shares in the last quarter. Finally, BlackRock Inc. boosted its holdings in shares of Surgery Partners by 3.9% in the first quarter. BlackRock Inc. now owns 3,807,392 shares of the company’s stock valued at $131,241,000 after acquiring an additional 143,719 shares in the last quarter.

Surgery Partners Company Profile

(Get Rating)

Surgery Partners, Inc is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services.